Monash University
Clinical trials sponsored by Monash University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New trial aims to shield blood cancer patients from deadly infections Results expected Mar 2027 (estimated)
- New trial aims to stop infections in blood cancer patients Results expected Mar 2027 (estimated)
- Can a simple antibiotic or immunoglobulin shield blood cancer patients from deadly infections? Results expected Mar 2027 (estimated)
- Can immunoglobulin or antibiotics stop infections in blood cancer patients? Results expected Mar 2027 (estimated)
- Hidden syphilis: new study targets silent spread in women and straight men Results expected Jun 2027 (estimated)
-
New study aims to shield vulnerable groups from COVID-19
Vaccine OngoingThis study tests whether extra COVID-19 vaccine doses are safe and work well for people with weakened immune systems, such as those with HIV, organ transplants, or blood cancers. Around 960 participants will receive different booster schedules to see which one boosts their protec…
Phase 3 • Sponsor: Monash University • Aim: Vaccine
Last updated Jun 27, 2026 07:53 UTC
-
Chestnuts may be a secret weapon for blood sugar control, new study hints
Knowledge-focused OngoingThis study looks at how eating chestnuts affects blood sugar and insulin levels after a meal in healthy adults. Researchers want to see if chestnuts, which are high in fiber and starch, can help manage blood sugar better than other foods. Fifteen healthy adults will participate i…
Sponsor: Monash University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC